Search

Robust signals of clinical efficacy, with ORR of 83%, of which 67% are CR/CRi and five patients with responses longer than 1 year

Radiomics is revolutionising medical image interpretation

The pandemic has provided an opportunity for Spanish biotechnology and private investment has increased by 50% in 2020. BIOSPAIN 2021, the reference Spanish trade fair for investment agents and

In a recent Phase 2a trial, TVB-2640 improved serum biomarkers of liver injury in patients with nonalcoholic steatohepatitis (NASH). OWL has worked since 2019 as the provider of metabolomics services

The objectives were clear: communicate the brand's values, encourage customer attraction, entice more candidates and retain current customers.

Ysios BioFund 3 (YBF 3) is the firm’s largest fund to date. To invest in up to 15 companies in Europe and the US, with eight investments already made alongside top US and European investors

Biotech companies are expanding their workforce amid the pandemic, accentuating in 2020 the growth trend of recent years, in which staff increased by 7.6% in 2019 and accounted for 12.8% of people

The conferences are: BioEquity Europe Digital, Foro Medcap BME 2021, Oxford Global’s Online Drug Discovery Week, Jefferies Virtual Healthcare Conference 2021, Precision in Drug Discovery & Preclinical

Asabys, who has been in business for almost 3 years, has considered sustainability as a fundamental pillar of its strategic objectives since inception

La compañía invierte 3,6 M€ en I+D sin impactos significativos derivados de la pandemia covid-19

3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications

Biotech company Cytoki Pharma (Copenhagen, Denmark) develops new proteins based on interleukin 22 (IL-22) for the treatment of epithelial lesions